Results 51 to 60 of about 3,766 (196)

Effects of Biological Sex and Age on Cerebrospinal Fluid Markers—A Retrospective Observational Study

open access: yesAnnals of Clinical and Translational Neurology, Volume 13, Issue 6, Page 1222-1235, June 2026.
ABSTRACT Objective Cerebrospinal fluid (CSF) analysis is a key diagnostic tool for neurological diseases. To date, only a few studies have investigated in larger cohorts the effect of age and biological sex on diagnostic markers extracted from CSF. Methods For this retrospective observational study, 4163 CSF findings (2012–2020) were evaluated.
Isabel‐Sophie Hafer   +3 more
wiley   +1 more source

Intraosseous sarcoidosis imitating peri‐implantitis: A case study

open access: yesClinical Advances in Periodontics, Volume 16, Issue 2, Page 251-259, June 2026.
Abstract Background Sarcoidosis is a multisystem granulomatous disorder of unknown cause, typically affecting the lungs and lymph nodes, but it can also involve the eyes, skin, heart, bones, and other organs. The exact cause is unclear, but genetic factors and environmental triggers like infections, chemicals, or dust may play a role.
Magdalena Orlowska   +2 more
wiley   +1 more source

Medically refractory neurosarcoidosis treated with infliximab.

open access: yes, 2011
Neurosarcoidosis can worsen despite standard immunosuppressive therapy, a situation for which there is no established medical management. We present three cases of medically refractory neurosarcoidosis treated with infliximab. All three patients showed a
Bergin, P   +11 more
core   +1 more source

Neurosarcoidosis Mimicking the Recurrence of Malignant Lymphoma

open access: yesCase Reports in Neurology, 2021
A 67-year-old woman with a recurrent history of malignant lymphoma (ML) presented with muscle weakness and paresthesia of the fingertips and feet. Due to the elevated level of serum soluble interleukin-2 receptor and increased 18F-fluorodeoxyglucose ...
Keishu Murakami   +3 more
doaj   +1 more source

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group

open access: yes, 2018
IMPORTANCE The Neurosarcoidosis Consortium Consensus Group, an expert panel of physicians experienced in the management of patients with sarcoidosis and neurosarcoidosis, engaged in an iterative process to define neurosarcoidosis and develop a practical ...
Tavee, Jinny   +13 more
core   +1 more source

Clinically isolated neurosarcoidosis: A recommended diagnostic path [PDF]

open access: yes, 2015
The involvement of the central nervous system in sarcoidosis can manifest with a variety of neurological symptoms, most of them nonspecific. We identified 13 patients with neurosarcoidosis diagnosed at our clinic.
Martin, Roland   +4 more
core   +1 more source

Unusual Clinical Course of Neurosarcoidosis Manifested with Acute Hydrocephalus

open access: yesActa Clinica Croatica, 2021
Approximately 5% to 15% of patients with systemic sarcoidosis develop neurological complications. However, the actual prevalence of subclinical disease may be higher.
Dragana Jovanović   +5 more
doaj   +1 more source

Cyclic Recurrence of Seizures as a Marker for Super‐Refractory Status Epilepticus

open access: yesBrain and Behavior, Volume 16, Issue 5, May 2026.
ABSTRACT Background Continuous EEG (cEEG) monitoring during status epilepticus (SE) has enabled the identification of cyclic seizures, characterized by recurrent seizures at regular intervals. However, their clinical implications and prognostic significance remain underexplored.
Maeva Le Goïc   +10 more
wiley   +1 more source

Defining the course of neurosarcoidosis according to presentation at onset and disease modifying treatment: a cohort study of 84 patients

open access: yesTherapeutic Advances in Neurological Disorders, 2023
Background: Neurosarcoidosis is a rare manifestation of sarcoidosis with heterogeneous presentations. Patient management is challenging due to the current lack of knowledge about the long-term disease course.
Inès Bekkour   +5 more
doaj   +1 more source

Cerebrospinal Fluid sCD27 as a Biomarker of Neuroinflammatory Disease: A Systematic Review and Meta‐Analysis

open access: yesJournal of Neurochemistry, Volume 170, Issue 5, May 2026.
Neuroinflammatory diseases of the CNS are difficult to diagnose, and current CSF biomarkers lack sensitivity across conditions. Soluble CD27 (sCD27), a marker of adaptive immune activation, has emerged as a promising candidate, but its clinical utility remains uncertain.
Nadia Damholt Savino   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy